162 related articles for article (PubMed ID: 37147212)
1. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.
Plata M; Cesar DR; Badillo N
Eur Urol; 2023 Jul; 84(1):e24-e25. PubMed ID: 37147212
[No Abstract] [Full Text] [Related]
2. Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolás Badillo's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.
Ilie G; David Harold Rutledge R
Eur Urol; 2023 Jul; 84(1):e26-e27. PubMed ID: 37127468
[No Abstract] [Full Text] [Related]
3. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. 2023;83:561-70.
Mai Z; Yan W; Zhou Z
Eur Urol; 2023 Aug; 84(2):e46-e47. PubMed ID: 37244814
[No Abstract] [Full Text] [Related]
4. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Pontes-Silva A
Eur Urol; 2024 Feb; 85(2):e43-e44. PubMed ID: 37758572
[No Abstract] [Full Text] [Related]
5. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
May M; Wolff I; Brookman-May SD
Eur Urol; 2024 Feb; 85(2):e47-e48. PubMed ID: 37743196
[No Abstract] [Full Text] [Related]
6. Reply to André Pontes-Silva's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Ilie G; Rutledge RDH
Eur Urol; 2024 Feb; 85(2):e45-e46. PubMed ID: 37743197
[No Abstract] [Full Text] [Related]
7. Reply to Zhipeng Mai, Weigang Yan, and Zhien Zhou's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Ilie G; Rutledge RDH
Eur Urol; 2023 Aug; 84(2):e48-e49. PubMed ID: 37244817
[No Abstract] [Full Text] [Related]
8. Reply to Matthias May, Ingmar Wolff, and Sabine D. Brookman-May's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Ilie G; Rutledge RDH
Eur Urol; 2024 Feb; 85(2):e49-e50. PubMed ID: 37743193
[No Abstract] [Full Text] [Related]
9. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial.
Ilie G; Rendon R; Mason R; MacDonald C; Kucharczyk MJ; Patil N; Bowes D; Bailly G; Bell D; Lawen J; Ha M; Wilke D; Massaro P; Zahavich J; Kephart G; Rutledge RDH
Eur Urol; 2023 Jun; 83(6):561-570. PubMed ID: 36822969
[TBL] [Abstract][Full Text] [Related]
10. Re: A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial.
Majumdar JR; Carlsson SV
Eur Urol; 2023 Sep; 84(3):349-350. PubMed ID: 37188550
[No Abstract] [Full Text] [Related]
11. Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036.
Ayubi E; Safiri S
Eur Urol; 2017 Dec; 72(6):e157. PubMed ID: 28576506
[No Abstract] [Full Text] [Related]
12. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.007.
Wei Y; Ye D; Zhu Y
Eur Urol; 2022 Aug; 82(2):e51. PubMed ID: 35599186
[No Abstract] [Full Text] [Related]
13. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.
Trock BJ; Karnes RJ
Eur Urol; 2017 Dec; 72(6):e158-e159. PubMed ID: 28576503
[No Abstract] [Full Text] [Related]
14. Re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.
Sahu KK
Eur Urol; 2022 Jun; 81(6):e146. PubMed ID: 35232602
[No Abstract] [Full Text] [Related]
15. Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
Parker C; Sydes MR; Kynaston H;
Eur Urol; 2013 Nov; 64(5):e102. PubMed ID: 23953599
[No Abstract] [Full Text] [Related]
16. Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77: 508-47 https://doi.org/10.1016/j.eururo.2020.01.012.
von Eyben FE; Bauman G; Soydal C; Paganelli G
Eur Urol; 2020 Nov; 78(5):e201-e202. PubMed ID: 32222292
[No Abstract] [Full Text] [Related]
17. Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.015.
Cimadamore A; Lopez-Beltran A; Cheng L; Montironi R
Eur Urol; 2023 Mar; 83(3):e84-e86. PubMed ID: 36517350
[No Abstract] [Full Text] [Related]
18. Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.02.009.
van den Bergh RCN; Valerio M; Tilki D; Gandaglia G;
Eur Urol; 2020 Aug; 78(2):e67-e68. PubMed ID: 32303383
[No Abstract] [Full Text] [Related]
19. Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
Du J; Liu Y; Yan W
Eur Urol; 2020 Aug; 78(2):e64. PubMed ID: 32362499
[No Abstract] [Full Text] [Related]
20. Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.
Kerkmeijer LGW; Pos FJ; van der Heide UA; Israël B; Draulans C; Haustermans K
Eur Urol; 2022 Jun; 81(6):e147-e148. PubMed ID: 35339319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
